Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the intergroup rhabdomyosarcoma study group

Philip P. Breitfeld, Elizabeth Lyden, R. Beverly Raney, Lisa A. Teot, Moody Wharam, Thom Lobe, William M. Crist, Harold M. Maurer, Sarah S. Donaldson, Frederick B. Ruymann, James R. Anderson, Richard J. Andrassy, Carola A.S. Arndt, K. Scott Baker, Frederic G. Barr, W. Archie Bleyer, Philip Breitfeld, John C. Breneman, Julia Bridge, Kenneth BrownHolcombe E. Grier, Douglas Hawkins, Peter J. Houghton, Michael Link, William H. Meyer, Jeff Michalski, Sharon Murphy, Charles N. Paidas, Alberto S. Pappo, David M. Parham, Stephen J. Qualman, Leslie Robison, Eric Sandler, Lynn Smith, Poul H.B. Sorensen, Lisa Teot, Timothy Triche, Teresa J. Vietti, David Walterhouse, Eugene S. Wiener, Suzanne Wolden, Richard Womer, Joan L. Leeson

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint Dive into the research topics of 'Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: A report from the intergroup rhabdomyosarcoma study group'. Together they form a unique fingerprint.

Medicine & Life Sciences